Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.

@article{Pitter2007CosteffectivenessOC,
  title={Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda.},
  author={Christian S. Pitter and James G. Kahn and Elliot Marseille and John R Lule and Deborah A McFarland and John Paul Ekwaru and Rebecca A Bunnell and Alex Coutinho and Jonathan Mermin},
  journal={Journal of acquired immune deficiency syndromes},
  year={2007},
  volume={44 3},
  pages={336-43}
}
BACKGROUND Daily prophylaxis with trimethoprim-sulfamethoxazole (cotrimoxazole) by persons with HIV reduces morbidity and mortality and is recommended by Joint United Nations Program on HIV/AIDS and World Health Organization (WHO), but there are limited published cost-effectiveness data for this intervention. We assessed the cost-effectiveness of cotrimoxazole prophylaxis for persons living with HIV in rural Uganda. METHODS We modeled the cost-effectiveness of daily cotrimoxazole prophylaxis… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…